New scan within 48 hours of brain tumor surgery could spot leftover cancer

NCT ID NCT07274397

Recruiting now Diagnosis Sponsor: Beta Emitting Accurate Monitored Systems Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a special brain scan (PET-MRI) done within 48 hours after glioblastoma surgery is safe and practical. Fifteen adults who just had their first surgery for a suspected glioblastoma will get this scan, which uses a radioactive tracer and contrast dye. The goal is to see if this early scan can find leftover tumor better than standard MRI, without causing harm.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: 18F-DOPA radiotracer and gadolinium contrast
What this could lead to: If successful, this imaging method could help surgeons see remaining tumor more clearly right after surgery, guiding further treatment decisions.
What could go wrong: This is a very small, early feasibility study with only 15 patients, so results may not apply broadly. The imaging itself carries minor radiation exposure and contrast risks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRAIN IMAGING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain cancer brain neoplasm glioblastoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BRAIN IMAGING BRAIN TUMORS GLIOBLASTOMA

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Hôpital Henri Mondor - Université Paris-Est Créteil (UPEC)
RECRUITING

Créteil, 94010, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.